Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer-Specific Death in Squamous Cell Carcinoma

被引:140
作者
Lu, Shaohua [1 ,2 ,3 ]
Tan, Kay See [4 ]
Kadota, Kyuichi [1 ,2 ,5 ]
Eguchi, Takashi [2 ,6 ]
Bains, Sarina [2 ]
Rekhtman, Natasha [1 ]
Adusumilli, Prasad S. [2 ,7 ]
Travis, William D. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10021 USA
[3] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[5] Kagawa Univ, Dept Diagnost Pathol, Fac Med, Takamatsu, Kagawa 760, Japan
[6] Shinshu Univ, Dept Surg, Div Thorac Surg, Matsumoto, Nagano, Japan
[7] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
Lung; Competing risks analysis; Spread through air spaces; Squamous cell carcinoma; EXTRANEOUS TISSUE; COMPETING RISKS; POOR-PROGNOSIS; TUMOR SPREAD; INVASION; IMPACT; RESECTION; COLLEGE; PATTERN;
D O I
10.1016/j.jtho.2016.09.129
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Spread through air spaces (STAS) is a recently recognized pattern of invasion in lung adenocarcinoma; however, it has not yet been characterized in squamous cell carcinoma (SCC). Methods: We reviewed 445 resected stage I to III lung SCCs and investigated the clinical significance of STAS. Cumulative incidence of recurrence and lung cancer-specific death were evaluated by competing risks analyses and overall survival by Cox models. Results: Of the total 445 patients, 336 (76%) were older than 65 years. Among the 273 patients who died, 91 (33%) died of lung cancer whereas the remaining ones died of competing events or unknown cause. STAS was observed in 132 patients (30%) and the frequency increased with stage. The cumulative incidences of any, distant, and locoregional recurrence as well as lung cancer-specific death were significantly higher in patients with STAS compared with in those without STAS, whereas there was no statistically significant difference in overall survival. In multivariable models for any recurrence and lung cancer-specific death, STAS was an independent predictor for both outcomes (p = 0.034 and 0.016, respectively). Conclusion: STAS was present in one-third of resected lung SCCs. In competing risks analysis in a cohort in which three fourths of the patients were elderly, STAS was associated with lung cancer-specific outcomes. Our findings suggest that STAS is one of the most prognostically significant histologic findings in lung SCC. (C) 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:223 / 234
页数:12
相关论文
共 35 条
  • [1] [Anonymous], J THORAC ONCOL
  • [2] [Anonymous], NCCN GUID SURV FOLL
  • [3] [Anonymous], PROT EX SPEC PAT PRI
  • [4] Competing Risk Analyses: How Are They Different and Why Should You Care?
    Chappell, Rick
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2127 - 2129
  • [5] The Use and Interpretation of Competing Risks Regression Models
    Dignam, James J.
    Zhang, Qiang
    Kocherginsky, Masha
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2301 - 2308
  • [6] American College of Chest Physicians and Society of Thoracic Surgeons Consensus Statement for Evaluation and Management for High-Risk Patients With Stage I Non-small Cell Lung Cancer
    Donington, Jessica
    Ferguson, Mark
    Mazzone, Peter
    Handy, John, Jr.
    Schuchert, Matthew
    Fernando, Hiran
    Loo, Billy, Jr.
    Lanuti, Michael
    de Hoyos, Alberto
    Detterbeck, Frank
    Pennathur, Arjun
    Howington, John
    Landreneau, Rodney
    Silvestri, Gerard
    [J]. CHEST, 2012, 142 (06) : 1620 - 1635
  • [7] Edge S.B., 2010, AJCC cancer staging manual, V649
  • [8] Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung
    Funai, K
    Yokose, T
    Ishii, G
    Araki, K
    Yoshida, J
    Nishimura, M
    Nagai, K
    Nishiwaki, Y
    Ochiai, A
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (07) : 978 - 984
  • [9] Gephardt GN, 1996, ARCH PATHOL LAB MED, V120, P1009
  • [10] Frequent aerogenous spread with decreased E-cadherin expression of ROS1-rearranged lung cancer predicts poor disease-free survival
    Jin, Yan
    Sun, Ping-Li
    Park, Soo Young
    Kim, Hyojin
    Park, Eunhyang
    Kim, Gilhyang
    Cho, Sukki
    Kim, Kwhanmien
    Lee, Choon-Taek
    Chung, Jin-Haeng
    [J]. LUNG CANCER, 2015, 89 (03) : 343 - 349